Nav: Home

'FishTaco' sorts out who is doing what in your microbiome

January 19, 2017

A growing body of evidence indicates that the trillions of microbes that live on and inside our bodies affect our health. Collectively, these resident microbes form our microbiome.

Earlier research has found, for example, that changes in the species composition of bacterial communities living in our intestines lead to imbalances in the set of metabolic processes the microbiome can perform. Such imbalances are associated with several conditions, including obesity, type 2 diabetes, cancer, and autoimmune diseases.

These observations suggest that it might be possible to prevent or treat these conditions by altering the composition of species in our microbiome through diet, drugs, or other techniques and restoring its functional capacity.

To do this, it is necessary to determine which bacterial species are responsible for which functional imbalances. This is no mean feat as hundreds to thousands of bacterial species populate the human microbiome.

In a new paper appearing in the journal Cell Host & Microbe, researchers at the University of Washington report that they have developed a novel computational method that reveals how much different bacterial species contribute to disease-associated functional imbalances in the microbiome.

"This method allows us to pinpoint which microbial species in our microbiome are responsible for each functional imbalance so they can be targeted for therapy," said Elhanan Borenstein, the senior author of this paper and an associate professor of genome sciences at the University of Washington School of Medicine. Borenstein's lab studies the human microbiome and develops novel computational methods for modeling and analyzing the microbiome. Borenstein co-wrote the paper with Ohad Manor, a former postdoctoral fellow in his lab who spearheaded this method.

The method, called FishTaco, short for "Functional Shifts' Taxonomic Contributors," integrates the two most common approaches scientists use to profile the microbiome and to identity associations with disease. These are the taxonomic approach and the functional approach.

Briefly, the taxonomic approach looks at which species, or taxa, of microbes make up the microbiome. The functional approach, in contrast, looks at all the genes present in a microbiome.

Because genes code for the proteins that determine the microbiome's activity, the total gene content of the microbiome reveals what functions its microbial population is capable of performing. Put differently, the taxonomic approach asks, "Who is there?", whereas the functional approach queries, "What are they doing?"

The problem, however, is that neither one of these two approaches tells the whole story, because many diseases are associated with changes in both the taxonomic and functional content of the microbiome. More important, it was not clear how to combine these two approaches or how to determine the exact relationship between taxonomic and functional disease associations.

"FishTaco integrates the taxonomic and functional approaches, linking shifts in the microbiome's species and gene compositions and identifying the taxa that drive functional imbalances observed in different diseases," Borenstein said.

In their study, Borenstein and Manor also used FishTaco to analyze the microbiomes of individuals with type 2 diabetes and inflammatory bowel disease and to identify the taxa contributing to functional imbalances in these diseases. They found that functional shifts are often driven by diverse combinations of species. Surprisingly, they further found that very similar functional imbalances observed in different diseases may in fact be driven by completely different set of species.

"Our findings demonstrate that the link between the microbiome taxonomic and functional dynamics is incredibly complex and disease-specific," said Borenstein. "Identifying the species that drive such imbalances in each disease is therefore an essential step toward targeted interventions aiming to manipulate the functional capacity of the microbiome and promote health."
-end-


University of Washington Health Sciences/UW Medicine

Related Diabetes Articles:

The role of vitamin A in diabetes
There has been no known link between diabetes and vitamin A -- until now.
Can continuous glucose monitoring improve diabetes control in patients with type 1 diabetes who inject insulin
Two studies in the Jan. 24/31 issue of JAMA find that use of a sensor implanted under the skin that continuously monitors glucose levels resulted in improved levels in patients with type 1 diabetes who inject insulin multiple times a day, compared to conventional treatment.
Complications of type 2 diabetes affect quality of life, care can lead to diabetes burnout
T2D Lifestyle, a national survey by Health Union of more than 400 individuals experiencing type 2 diabetes (T2D), reveals that patients not only struggle with commonly understood complications, but also numerous lesser known ones that people do not associate with diabetes.
Type 2 diabetes and obesity -- what do we really know?
Social and economic factors have led to a dramatic rise in type 2 diabetes and obesity around the world.
A better way to predict diabetes
An international team of researchers has discovered a simple, accurate new way to predict which women with gestational diabetes will develop type 2 diabetes after delivery.
The Lancet Diabetes & Endocrinology: Older Americans with diabetes living longer without disability, US study shows
Older Americans with diabetes born in the 1940s are living longer and with less disability performing day to day tasks than those born 10 years earlier, according to new research published in The Lancet Diabetes & Endocrinology journal.
Reverse your diabetes -- and you can stay diabetes-free long-term
A new study from Newcastle University, UK, has shown that people who reverse their diabetes and then keep their weight down remain free of diabetes.
New cause of diabetes
Although insulin-producing cells are found in the endocrine tissue of the pancreas, a new mouse study suggests that abnormalities in the exocrine tissue could cause cell non-autonomous effects that promotes diabetes-like symptoms.
The Lancet Diabetes & Endocrinology: Reducing sugar content in sugar-sweetened drinks by 40 percent over 5 years could prevent 1.5 million cases of overweight and obesity in the UK and 300,000 cases of diabetes
A new study published in The Lancet Diabetes & Endocrinology journal suggests that reducing sugar content in sugar sweetened drinks (including fruit juices) in the UK by 40 percent over five years, without replacing them with any artificial sweeteners, could prevent 500,000 cases of overweight and 1 million cases of obesity, in turn preventing around 300,000 cases of type 2 diabetes, over two decades.
Breastfeeding lowers risk of type 2 diabetes following gestational diabetes
Women with gestational diabetes who consistently and continuously breastfeed from the time of giving birth are half as likely to develop type 2 diabetes within two years after delivery, according to a study from Kaiser Permanente published today in Annals of Internal Medicine.

Related Diabetes Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Moving Forward
When the life you've built slips out of your grasp, you're often told it's best to move on. But is that true? Instead of forgetting the past, TED speakers describe how we can move forward with it. Guests include writers Nora McInerny and Suleika Jaouad, and human rights advocate Lindy Lou Isonhood.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...